Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,378 | 58 | 93.3% |
| Education | $99.00 | 1 | 6.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medicure Pharma Inc. | $302.55 | 1 | $0 (2020) |
| GlaxoSmithKline, LLC. | $177.68 | 10 | $0 (2023) |
| Astellas Pharma US Inc | $170.18 | 6 | $0 (2019) |
| Qiagen, LLC | $118.59 | 4 | $0 (2019) |
| Amarin Pharma Inc. | $109.01 | 2 | $0 (2019) |
| Gilead Sciences, Inc. | $104.32 | 2 | $0 (2020) |
| Novo Nordisk Inc | $57.89 | 4 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $57.54 | 4 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $57.15 | 4 | $0 (2021) |
| AbbVie Inc. | $43.75 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $12.75 | 1 | GlaxoSmithKline, LLC. ($12.75) |
| 2022 | $14.00 | 1 | GlaxoSmithKline, LLC. ($14.00) |
| 2021 | $69.02 | 5 | AbbVie Inc. ($28.75) |
| 2020 | $472.73 | 9 | Medicure Pharma Inc. ($302.55) |
| 2019 | $578.52 | 21 | Astellas Pharma US Inc ($125.73) |
| 2018 | $201.92 | 14 | Astellas Pharma US Inc ($44.45) |
| 2017 | $127.63 | 8 | Merck Sharp & Dohme Corporation ($42.96) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/12/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: VACCINES | ||||||
| 09/01/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: VACCINES | ||||||
| 04/15/2021 | Horizon Therapeutics plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: DUEXIS | ||||||
| 02/22/2021 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: VACCINES | ||||||
| 02/22/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: DIABETES | ||||||
| 12/11/2020 | Medicure Pharma Inc. | HMG-CoA reductase inhibitor. (Drug) | Food and Beverage | In-kind items and services | $302.55 | General |
| Category: ZYPITAMAG (pitavastatin) | ||||||
| 11/04/2020 | Medtronic USA, Inc. | VECTRIS (Device) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/20/2020 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: VACCINES | ||||||
| 09/24/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/21/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: DIABETES | ||||||
| 09/03/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Endocrinology | ||||||
| 07/17/2020 | Horizon Therapeutics plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: DUEXIS | ||||||
| 07/08/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: DIABETES | ||||||
| 03/04/2020 | Gilead Sciences, Inc. | Descovy (Drug) | Food and Beverage | In-kind items and services | $74.32 | General |
| Category: HIV | ||||||
| 11/25/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Obesity | ||||||
| 11/07/2019 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.00 | General |
| 11/07/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: UROLOGY | ||||||
| 11/05/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $94.02 | General |
| Category: Hypertriglyceridemia | ||||||
| 09/26/2019 | Novartis Pharmaceuticals Corporation | ILARIS (Biological) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2019 | SANOFI PASTEUR INC. | ADACEL (Drug), FLUZONE HIGH-DOSE, FLUZONE QUADRIVALENT | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: VACCINES | ||||||
| 07/29/2019 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: DIABETES | ||||||
| 07/11/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: UROLOGY | ||||||
| 06/22/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, BASAGLAR | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 157 | 229 | $73,910 | $18,634 |
| 2022 | 6 | 215 | 301 | $83,095 | $23,426 |
| 2021 | 5 | 175 | 302 | $96,270 | $27,327 |
| 2020 | 10 | 393 | 842 | $159,560 | $40,588 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 66 | 113 | $42,080 | $9,499 | 22.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 73 | $18,845 | $4,529 | 24.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 30 | 30 | $11,785 | $4,165 | 35.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 13 | 13 | $1,200 | $441.61 | 36.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 68 | 135 | $48,600 | $11,472 | 23.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 43 | 43 | $16,340 | $6,149 | 37.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 57 | $13,965 | $3,501 | 25.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 18 | 19 | $1,710 | $1,299 | 76.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 20 | 21 | $1,050 | $708.18 | 67.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 25 | 26 | $1,430 | $298.05 | 20.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 87 | 212 | $76,320 | $19,723 | 25.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 34 | 34 | $12,920 | $5,069 | 39.2% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 18 | 18 | $1,620 | $1,175 | 72.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 18 | $4,410 | $969.64 | 22.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 20 | 20 | $1,000 | $390.60 | 39.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 111 | 227 | $81,720 | $16,196 | 19.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 58 | 58 | $22,040 | $7,558 | 34.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 79 | 135 | $33,075 | $6,944 | 21.0% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2020 | 16 | 16 | $3,500 | $3,301 | 94.3% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2020 | 13 | 248 | $11,160 | $3,005 | 26.9% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 29 | 29 | $2,610 | $1,744 | 66.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 34 | 35 | $1,750 | $664.85 | 38.0% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2020 | 13 | 52 | $1,820 | $497.56 | 27.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 23 | 25 | $1,375 | $357.86 | 26.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 17 | 17 | $510.00 | $320.81 | 62.9% |
About Dr. Samih Abbassi, MD
Dr. Samih Abbassi, MD is a Internal Medicine healthcare provider based in West Orange, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1750380358.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samih Abbassi, MD has received a total of $1,477 in payments from pharmaceutical and medical device companies, with $12.75 received in 2023. These payments were reported across 59 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,378).
As a Medicare-enrolled provider, Abbassi has provided services to 940 Medicare beneficiaries, totaling 1,674 services with total Medicare billing of $109,976. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location West Orange, NJ
- Active Since 07/18/2005
- Last Updated 01/28/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1750380358
Products in Payments
- HMG-CoA reductase inhibitor. (Drug) $302.55
- MDX QUANTIFERON (Device) $118.59
- Vascepa (Drug) $109.01
- BEXSERO (Biological) $75.46
- Descovy (Drug) $74.32
- MYRBETRIQ (Drug) $57.45
- JARDIANCE (Drug) $57.15
- SHINGRIX (Biological) $54.86
- JANUVIA (Drug) $42.96
- ENTRESTO (Drug) $40.56
- ADVAIR (Drug) $34.58
- CONTRAVE (Drug) $33.56
- Truvada (Drug) $30.00
- DUEXIS (Drug) $28.73
- Tresiba (Drug) $28.36
- EUFLEXXA (Device) $26.77
- TRULICITY (Drug) $23.28
- ILARIS (Biological) $16.98
- LifeVest (Device) $16.53
- Creon (Drug) $15.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in West Orange
Dr. David Dobesh, Md, MD
Internal Medicine — Payments: $83,628
Dr. Abel Gonzalez, M.d, M.D
Internal Medicine — Payments: $21,675
Dr. David Rahni, M.d, M.D
Internal Medicine — Payments: $14,217
Alvin Schmidt, Md, MD
Internal Medicine — Payments: $13,264
Andrew Baddoo, M.d, M.D
Internal Medicine — Payments: $12,461
Larry Siu, Md, MD
Internal Medicine — Payments: $10,598